http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29159598

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 4429
issn 1178-6930
pageRange 4413-4429
publicationName OncoTargets and Therapy
startingPage 4413
bibliographicCitation Xue Y, Yang L, Li J, Yan Y, Jiang Q, Shen L, Yang S, Shen B, Huang R, Yan J, Guo H. Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway. Onco Targets Ther. 2018;11():4413–29. PMID: 30104883; PMCID: PMC6072829.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5a09808af0e1fe7a79fff6a191725f0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9856835caaed1fd41d7a7c3d86b4e30
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8f8cf043e014395a85e3a5c3bb7d0aa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0c9587ab81ecf6ba4d7ed8c10307017
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_092b344bb4fe739f34ad987bb0307019
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1450309a5901dd9e69659aa1939b0862
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1c3f6fd83fe563265be5531ef548e01
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1303-1952
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c590153e3eb271166f884f4c1733ba3a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3553486ceea949cead1e1e8674c00a8f
date 201807
identifier https://pubmed.ncbi.nlm.nih.gov/30104883
https://doi.org/10.2147/ott.s162255
https://pubmed.ncbi.nlm.nih.gov/PMC6072829
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37198
https://portal.issn.org/resource/ISSN/1178-6930
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8b5b5bdbd09585ee176b45bc35e769ad
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_744117db1e81ab1e4aebb6f186b13f7d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f77be2a38ebd4e1357d44f6abac2461c

Total number of triples: 35.